Anish; Chakkumkal

Patent Applications and Registrations

Patent applications and USPTO patent grants for Anish; Chakkumkal.The latest application filed is for "synthetic vaccines against streptococcus pneumoniae serotype 2".

Company Profile

6.10.11

Anish; Chakkumkal - The Hague NL
Anish; Chakkumkal - Den Haag NL
Anish; Chakkumkal - Berlin DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Synthetic vaccines against Streptococcus pneumoniae serotype 2 Grant 10,864,261 - Seeberger , et al. December 15, 2	2020-12-15
Vaccines against carbapenem-resistant Klebsiella pneumoniae Grant 10,688,169 - Seeberger , et al.	2020-06-23
Vaccines against Streptococcus pneumoniae serotype 5 Grant 10,596,272 - Anish , et al.	2020-03-24
Synthetic Vaccines Against Streptococcus Pneumoniae Serotype 2 App 20200016257 - Seeberger; Peter H. ; et al.	2020-01-16
Synthetic vaccines against Streptococcus pneumoniae type 1 Grant 10,328,141 - Seeberger , et al.	2019-06-25
Vaccines against Streptococcus pneumoniae serotype 8 Grant 10,220,083 - Seeberger , et al.	2019-03-05
Vaccines against Streptococcus pneumoniae serotype 4 Grant 10,188,718 - Seeberger , et al. Ja	2019-01-29
Vaccines Against Streptococcus Pneumoniae Serotype 5 App 20180296687 - ANISH; Chakkumkal ; et al.	2018-10-18
Protein and peptide-free synthetic vaccines against Streptococcus pneumoniae type 3 Grant 10,052,373 - Rathwell , et al. August 21, 2	2018-08-21
Vaccines Against Carbapenem-resistant Klebsiella Pneumoniae App 20180078630 - Seeberger; Peter H. ; et al.	2018-03-22
Vaccines Against Streptococcus Pneumoniae Serotype 4 App 20170333545 - Seeberger; Peter H. ; et al.	2017-11-23
Antibodies for prevention and treatment of diseases caused by clostridium difficile Grant 9,815,889 - Seeberger , et al. November 14, 2	2017-11-14
Vaccines Against Streptococcus Pneumoniae Serotype 8 App 20170239341 - Seeberger; Peter H. ; et al.	2017-08-24
Synthetic Vaccines Against Streptococcus Pneumoniae Type 1 App 20160346374 - Seeberger; Peter H. ; et al.	2016-12-01
Protein And Peptide-free Synthetic Vaccines Against Streptococcus Pneumoniae Type 3 App 20160279224 - RATHWELL; Dominea ; et al.	2016-09-29
Antibodies For Prevention And Treatment Of Diseases Caused By Clostridium Difficile App 20160137724 - SEEBERGER; Peter H. ; et al.	2016-05-19
Oligosaccharides and oligosaccharide-protein conjugates derived from Clostridium difficile polysaccharide PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools Grant 9,238,669 - Seeberger , et al. January 19, 2	2016-01-19
Total Synthesis And Immunological Evaluation Of Saccharide Moieties Of The Lipopolysaccharide From Neisseria Meningitidis App 20140234364 - Seeberger; Peter H. ; et al.	2014-08-21
Oligosaccharides And Oligosaccharide-protein Conjugates Derived From Clostridium Difficle Polysaccaride Ps-i, Methods Of Synthesis And Uses Thereof, In Particular As Vaccines And Diagnostic Tools App 20140193416 - Seeberger; Peter H. ; et al.	2014-07-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.